These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28748694)

  • 21. Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model.
    Izuhara M; Kuwabara Y; Saito N; Yamamoto E; Hakuno D; Nakashima Y; Horie T; Baba O; Nishiga M; Nakao T; Nishino T; Nakazeki F; Ide Y; Kimura M; Kimura T; Ono K
    PLoS One; 2017; 12(3):e0172798. PubMed ID: 28253326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
    He X; Ma J; Mercado AE; Xu W; Jabbari E
    Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y; Xu Q; Chow PK; Wang D; Wang CH
    Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.
    López-Gasco P; Iglesias I; Benedí J; Lozano R; Teijón JM; Blanco MD
    J Microencapsul; 2011; 28(5):417-29. PubMed ID: 21736526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery.
    Wu P; Liu Q; Li R; Wang J; Zhen X; Yue G; Wang H; Cui F; Wu F; Yang M; Qian X; Yu L; Jiang X; Liu B
    ACS Appl Mater Interfaces; 2013 Dec; 5(23):12638-45. PubMed ID: 24274601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
    Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of gene transfer using nanoparticles as gene vector in different animal models].
    Yang J; Song CX; Li YJ; Guan H; Li DY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):475-80. PubMed ID: 16995296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
    Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
    Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.
    Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y
    Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles.
    Shi Y; Zhou M; Zhang J; Lu W
    J Microencapsul; 2015; 32(7):699-704. PubMed ID: 26004370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.
    Adjei IM; Sharma B; Peetla C; Labhasetwar V
    J Control Release; 2016 Jun; 232():83-92. PubMed ID: 27090164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-delivery of VEGF and PDGF by double-layered electrospun membranes for blood vessel regeneration.
    Zhang H; Jia X; Han F; Zhao J; Zhao Y; Fan Y; Yuan X
    Biomaterials; 2013 Mar; 34(9):2202-12. PubMed ID: 23290468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation.
    Zhang H; Tian Y; Zhu Z; Xu H; Li X; Zheng D; Sun W
    Sci Rep; 2016 May; 6():26546. PubMed ID: 27226240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supramolecular hydrogel based on high-solid-content mPECT nanoparticles and cyclodextrins for local and sustained drug delivery.
    Yin L; Xu S; Feng Z; Deng H; Zhang J; Gao H; Deng L; Tang H; Dong A
    Biomater Sci; 2017 Mar; 5(4):698-706. PubMed ID: 28184404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
    Şalva E; Turan SO; Kabasakal L; Alan S; Özkan N; Eren F; Akbuğa J
    J Pharm Sci; 2014 Mar; 103(3):785-95. PubMed ID: 24357345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.
    Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q
    Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.